
CHAIR
Mark Hallett,MD
President-elect
International Federation of Clinical Neurophysiology
Bethesda, MD
|
|
|
- (February 2014) Medicines and Healthcare Regulatory Products Agency (UK) approves Botox® (onabotulinumtoxinA) for the treatment of ankle disability due to lower limb spasticity associated with stroke in adults.
|

Alberto Albanese, MD
Professor of Neurology
Istituto Nazionale Neurologico Carlo Besta
Università Cattolica del Sacro Cuore
Milan, Italy
|
|
|
M. Zouhair Atassi, PhD, DSc
Robert A. Welch Chair of Chemistry
Professor of Biochemistry, Molecular Biology, and Immunology
Baylor College of Medicine
Houston, Texas
|

Allison Brashear, MD
Professor and Chair, Dept of Neurology
Wake Forest University School of Medicine
Winston-Salem, North Carolina
|
|
|

Michael B. Chancellor, MD
Professor, Oakland University William Beaumont School of Medicine
Director of Neurology Program
Department of Urology
William Beaumont Hospital
Royal Oak, Michigan
|
|
|

J. Oliver Dolly, MSc, PhD, DSc
SFI Professor of Neurotherapeutics
International Center for Neurotherapeutics
Dublin City University
Dublin, Ireland
|
|
|

Alberto Esquenazi, MD
Chair, Department of Physical Medicine and Rehabilitation Director, Gait & Motion Analysis Laboratory MossRehab Albert Einstein Healthcare Network Elkins Park, Pennsylvania |
|
|

F. Michael Ferrante, MD
Director, UCLA Pain Management Center Professor of Clinical Anesthesiology and Medicine University of California Los Angeles, California
|
|
|

Deborah Gaebler-Spira, MD
Professor
Department of Physical Medicine and Rehabilitation
Department of Pediatrics
Northwestern Feinberg School of Medicine
Chicago, Illinois
|
|
H. Kerr Graham, MD, FRCS (Ed), FRACS
Professor of Orthopaedic Surgery
Director of the Hugh Williamson Gait Laboratory
The Royal Children's Hospital
Melbourne, Australia
|
Joseph Jankovic, MD
Professor of Neurology, Distinguished Chair in Movement Disorders
Director, Parkinson Disease Center and Movement Disorders Clinic
Department of Neurology
Baylor College of Medicine
Houston, Texas
|
Nathaniel Mayer, MD
Emeritus Founder Director, Drucker Brain Injury Center Director, Motor Control Analysis Laboratory MossRehab Albert Einstein Healthcare Network Emeritus Professor of Physical Medicine and Rehabilitation Temple University Health Sciences Center Elkins Park, Pennsylvania
|

Markus Naumann, MD
Professor and Head of the Department of Neurology and Clinical Neurophysiology
Academic Hospital of the Ludwigs-Maximilians-University Munich
Klinikum Augsburg, Germany
|
|
|
Pankaj (Jay) Pasricha, MD
Chief, Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Stanford, California
|

Neil S. Sadick, MD, FAAD, FAACS, FACP, FACPh
Clinical Professor of Dermatology. Weill Cornell Medical College New York, New York
|
|

Giampietro Schiavo, PhD
Senior Group Leader
Molecular Neuropathobiology Laboratory
Cancer Research UK
London Research Institute
Lincoln's Inn Fields Laboratories
London, United Kingdom
|

Stephen D. Silberstein, MD
Professor of Neurology
Director, Jefferson Headache Center
Thomas Jefferson University
Philadelphia, Pennsylvania
|
|

David M. Simpson, MD
Professor of Neurology, Mount Sinai School of Medicine Director, Neuro-AIDS Program Mount Sinai Medical Center New York, New York
|
|
Leonard A. Smith, PhD
Scientific Consultant
Clarksburg, Maryland |
|
|